Delivery Order SPE2DB24D2205-SPE2DB25FDXDX
Award Date
1/22/25
Potential Completion Date
2/12/25
Potential Value
$7.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,325.64, is for the delivery of GAMUNEX-C 10 GRAM/100 ML VIAL 100ML, a pharmaceutical product, with a completion date of January 31, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued...
This federal contract award, valued at $3,606.60, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GAMUNEX-C 1 GRAM/10 ML VIAL 10ML, a pharmaceutical product, and has an ultimate completion date of November 21, 2024. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award, valued at $3,036.70, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GAMUNEX-C 5 gram/50 mL vials, a specialty medical product. It has an ultimate completion date of February 27, 2025. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,963.20, is for the delivery of GAMUNEX-C 40 GRAM/400 ML VIAL 400ML, a medical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is February 20, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,865.73 firm fixed-price delivery order is for the supply of GAMUNEX-C 10 GRAM/100 ML VIAL 100ML, a specialty medication. The contract has an ultimate completion date of January 13, 2025 and was awarded on December 19, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,133,843 units of the pharmaceutical product GAMUNEX-C 20 gram/200 ml vial. The contract has a ceiling value of $7,147.50 and a period of performance through April 22, 2024. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,963.20, is for the delivery of GAMUNEX-C 40 gram/400 ml vials, a specialty medication. The contract has an ultimate completion date of February 18, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This federal contract award, valued at $1,831.41, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GAMUNEX-C 10 gram/100 ml vials, with a completion date of February 4, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,022.70, is for the delivery of GAMUNEX-C, a 40 gram/400 ml vial of pharmaceutical product. The contract has a firm fixed price pricing type and a completion date of September 23, 2024. This award is a part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,731.46 firm fixed-price contract is for the supply of GAMUNEX-C 10 gram/100 ml vials, with a completion date of December 30, 2024. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for...